Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ovarian Neoplasms

Free Subscription 22.07.2019 1 Anticancer Drugs 1 BMC Cancer 1 Cancer Res 1 Eur J Obstet Gynecol Reprod Biol 1 Gynecol Oncol 1 Int J Oncol 1 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Anticancer Drugs

1. VILLA M, Attianese D, Petracchini M, Ferrero A, et al
   Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient.
   Anticancer Drugs. 2019 Jul 11. doi: 10.1097/CAD.0000000000000815.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. GONG W, Liu Y, Seidl C, Diamandis EP, et al
   Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
   BMC Cancer. 2019;19:696.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

3. FUKUMOTO T, Fatkhutdinov N, Zundell JA, Tcyganov EN, et al
   HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer.
   Cancer Res. 2019 Jul 16. pii: 0008-5472.CAN-19-1302.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

4. TOZZI R, Casarin J, Baysal A, Pinelli C, et al
   Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
   Eur J Obstet Gynecol Reprod Biol. 2019;240:215-219.
   PubMed     Text format     Abstract available
   
   

   
   Gynecol Oncol

5. XIANG L, Ye S, Yang H
   Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity.
   Gynecol Oncol. 2019 Jul 17. pii: S0090-8258(19)31352.
   PubMed     Text format     Abstract available
   
   

   
   Int J Oncol

6. SEKIYA A, Suzuki S, Tanaka A, Hattori S, et al
   Interleukin33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.
   Int J Oncol. 2019 Jul 17. doi: 10.3892/ijo.2019.4845.
   PubMed     Text format     Abstract available
   
   

   
   Oncol Rep

7. LUO H, Wang X, Ge H, Zheng N, et al
   Inhibition of ubiquitinspecific protease 14 promotes connexin 32 internalization and counteracts cisplatin cytotoxicity in human ovarian cancer cells.
   Oncol Rep. 2019 Jul 15. doi: 10.3892/or.2019.7232.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: